Cytori Therapeutics Inc (CYTX)-Financial and Strategic SWOT Analysis Review

Cytori Therapeutics Inc (CYTX)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH4264FSA
  • |
  • Pages: 48
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Cytori Therapeutics Inc (CYTX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cytori Therapeutics Inc (Cytori Therapeutics) is a clinical stage regenerative medicine company. It develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) for the treatment of cardiovascular disease, orthopedic conditions and gastrointestinal disorders. Cytori has two key product lines, namely, the Celution System family which comprises medical devices for use in cosmetic and reconstructive surgery and StemSource family for use in laboratory research and stem cell banking. The company offers its products to the physicians and patients at the point-of-care by its proprietary technologies and products. The company markets its cellular therapeutics under the trade name, Cytori Cell Therapy. Cytori Therapeutics is headquartered in San Diego, California, the US.

Cytori Therapeutics Inc Key Recent Developments

Nov 16, 2016: Cytori Strengthens Global Intellectual Property Portfolio with Key Patents

Nov 14, 2016: Cytori Granted FDA Orphan Drug Designation for ECCS-50 in Scleroderma

Nov 09, 2016: Cytori Reports Third Quarter 2016 Business and Financial Results

Oct 26, 2016: Cytori Presents Scleroderma Clinical Trial Data at the 2016 American College of Rheumatology Annual Meeting

Oct 24, 2016: Cytori Publication on Cytori Cell Therapy for Combined Radiation and Thermal Injury

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Cytori Therapeutics Inc-Key Facts 6

Cytori Therapeutics Inc-Key Employees 7

Cytori Therapeutics Inc-Key Employee Biographies 8

Cytori Therapeutics Inc-Major Products and Services 9

Cytori Therapeutics Inc-History 10

Cytori Therapeutics Inc-Company Statement 14

Cytori Therapeutics Inc-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Section 2-Company Analysis 17

Cytori Therapeutics Inc-Business Description 17

Cytori Therapeutics Inc-Corporate Strategy 18

Cytori Therapeutics Inc-SWOT Analysis 19

SWOT Analysis-Overview 19

Cytori Therapeutics Inc-Strengths 19

Cytori Therapeutics Inc-Weaknesses 20

Cytori Therapeutics Inc-Opportunities 21

Cytori Therapeutics Inc-Threats 22

Cytori Therapeutics Inc-Key Competitors 23

Section 3-Company Financial Ratios 24

Financial Ratios-Capital Market Ratios 24

Financial Ratios-Annual Ratios 25

Performance Chart 27

Financial Performance 27

Financial Ratios-Interim Ratios 28

Financial Ratios-Ratio Charts 29

Section 4-Company's Lifesciences Financial Deals and Alliances 30

Cytori Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 30

Cytori Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 31

Cytori Therapeutics Inc, Recent Deals Summary 32

Section 5-Company's Recent Developments 33

Nov 16, 2016: Cytori Strengthens Global Intellectual Property Portfolio with Key Patents 33

Nov 14, 2016: Cytori Granted FDA Orphan Drug Designation for ECCS-50 in Scleroderma 34

Nov 09, 2016: Cytori Reports Third Quarter 2016 Business and Financial Results 35

Oct 26, 2016: Cytori Presents Scleroderma Clinical Trial Data at the 2016 American College of Rheumatology Annual Meeting 36

Oct 24, 2016: Cytori Publication on Cytori Cell Therapy for Combined Radiation and Thermal Injury 37

Sep 26, 2016: Cytori Partner Kerastem Completes Enrollment of US Phase II Trial for Early Stage Hair Loss 38

Sep 19, 2016: BARDA Increases Contract Option with Cytori to Advance Countermeasure Clinical Trial 39

Aug 04, 2016: Cytori Reports Second Quarter 2016 Business and Financial Results 40

Jul 19, 2016: Cytori Cell Therapy Phase I Trial Reports Maxillofacial Bone Regeneration 42

Jun 27, 2016: Cytori Cell Therapy Receives Limited Approval for Osteoarthritis in Japan 43

Section 6-Appendix 44

Methodology 44

Ratio Definitions 44

About GlobalData 48

Contact Us 48

Disclaimer 48

List of Figures

Cytori Therapeutics Inc, Performance Chart (2011-2015) 27

Cytori Therapeutics Inc, Ratio Charts 29

Cytori Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 30

Cytori Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 31

List of Tables

Cytori Therapeutics Inc, Key Facts 6

Cytori Therapeutics Inc, Key Employees 7

Cytori Therapeutics Inc, Key Employee Biographies 8

Cytori Therapeutics Inc, Major Products and Services 9

Cytori Therapeutics Inc, History 10

Cytori Therapeutics Inc, Subsidiaries 16

Cytori Therapeutics Inc, Key Competitors 23

Cytori Therapeutics Inc, Ratios based on current share price 24

Cytori Therapeutics Inc, Annual Ratios 25

Cytori Therapeutics Inc (Cont...1), Annual Ratios 26

Cytori Therapeutics Inc, Interim Ratios 28

Cytori Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 30

Cytori Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 31

Cytori Therapeutics Inc, Recent Deals Summary 32

Currency Codes 44

Capital Market Ratios 44

Equity Ratios 45

Profitability Ratios 45

Cost Ratios 46

Liquidity Ratios 46

Leverage Ratios 46

Efficiency Ratios 47

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Cytori Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8431
Site License
USD 250 INR 16863
Corporate User License
USD 375 INR 25294

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com